AWARENESS OF HUMAN PAPILLOMA VIRUS AND VACCINE AMONG INDIAN LGBTQ+ INDIVIDUALS: A SURVEY STUDY
Main Article Content
Keywords
.
Abstract
Background: Human papillomavirus (HPV) is a prevalent sexually transmitted infection that can lead to various health complications, including cervical cancer and genital warts. While HPV vaccination is widely recommended for preventing HPV-related diseases, awareness and knowledge of the vaccine among marginalized populations, such as the Indian LGBTQ+ (Lesbian, Gay, Bisexual, and Transgender) community, remain understudied. Understanding the awareness and perceptions of HPV and its vaccine within this community is crucial for developing targeted public health interventions.
Materials & Methods: This survey study aimed to assess the level of awareness and knowledge of HPV and its vaccine among Indian LGBTQ+individuals. A structured questionnaire was designed to collect data on participants' demographic characteristics, awareness of HPV, knowledge about the HPV vaccine, and attitudes toward vaccination. The survey was distributed online through LGBTQ+ community forums and social media platforms to reach a diverse sample of Indian LGBTQ+ individuals. Participants were assured of confidentiality and voluntary participation.
Results: The study received responses from a diverse group of Indian LGBTQ+ individuals. The results revealed varying levels of awareness and knowledge about HPV and its vaccine within the community. A significant proportion of participants had limited awareness of HPV-related diseases and the availability of HPV vaccines. Moreover, misconceptions and myths surrounding HPV and vaccination were prevalent among some respondents. However, there were also participants who demonstrated a good understanding of HPV, its transmission, and the importance of vaccination.
Conclusion: The findings of this study highlight the need for targeted health education campaigns and interventions to increase awareness and knowledge of HPV and its vaccine among the Indian LGBTQ+ community. Improved access to accurate and culturally sensitive information about HPV vaccination is essential to empower individuals to make informed decisions about their sexual health and well-being. Health authorities and organizations should collaborate to develop tailored educational programs that address the unique needs and concerns of the LGBTQ+ population, ultimately promoting better health outcomes and reducing the burden of HPV-related diseases in this marginalized community.
References
2.Fakhry C, Westra WH, Li S. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst [Internet]. 2008;100. Available from: https://doi.org/10.1093/jnci/djn011
3.Shafti-Keramat S, Handisurya A, Kriehuber E. Different heparan sulfate proteoglycans serve as cellular receptors for human papillomaviruses. J Virol [Internet]. 2003;77. Available from: https://doi.org/10.1128/JVI.77.24.13125-13135.2003
4.Syrjänen S, Lodi G, Bültzingslöwen I. Human papillomaviruses in oral carcinoma and oral potentially malignant disorders: a systematic review. Oral Dis [Internet]. 2011;Suppl 1. Available from: https://doi.org/10.1111/j.1601-0825.2011.01792.x
5.Napolitano F, Napolitano P, Liguori G, Angelillo IF. Human papillomavirus infection and vaccination: Knowledge and attitudes among young males in Italy. Hum Vaccin Immunother. 2016 Jun 2;12(6):1504–10.
6.Bousarghin L, Touzé A, Sizaret PY, Coursaget P. Human papillomavirus types 16, 31, and 58 use different endocytosis pathways to enter cells. J Virol [Internet]. 2003;77. Available from: https://doi.org/10.1128/JVI.77.6.3846-3850.2003
7.Prue G, Shapiro G, Maybin R, Santin O, Lawler M. Knowledge and acceptance of human papillomavirus (HPV) and HPV vaccination in adolescent boys worldwide: A systematic review. Vol. 10, Journal of Cancer Policy. Elsevier Ltd; 2016. p. 1–15.
8.Griffin M, Jaiswal J, Stults CB. Human Papillomavirus Vaccination Rates by Gender Identity and Sexual Orientation Among 18–44-Year-Olds in the U.S. Arch Sex Behav. 2021 Oct 1;50(7):3079–92.
9.Strati K, Lambert PF. Human papillomavirus association with head and neck cancers: understanding virus biology and using it in the development of cancer diagnostics. Expert Opin Med Diagn [Internet]. 2008;2. Available from: https://doi.org/10.1517/17530059.2.1.11
10.Gichki AS, Buajeeb W, Doungudomdacha S, Khovidhunkit S on P. Knowledge of human papillomavirus and its association with head and neck benign and malignant lesions in a group of dental patients in Pakistan. Asian Pacific Journal of Cancer Prevention. 2015;16(4):1581–5.
11.Hansson BG, Rosenquist K, Antonsson A. Strong association between infection with human papillomavirus and oral and oropharyngeal squamous cell carcinoma: a population-based case–control study in southern Sweden. Acta Otolaryngol [Internet]. 2005;125. Available from: https://doi.org/10.1080/00016480510043945
12.Agénor M, Pérez AE, Peitzmeier SM, Potter J, Borrero S. Human Papillomavirus Vaccination Initiation among Sexual Orientation Identity and Racial/Ethnic Subgroups of Black and White U.S. Women and Girls: An Intersectional Analysis. J Womens Health. 2018 Nov 1;27(11):1349–58.
13.Disbrow GL, Hanover JA, Schlegel R. Endoplasmic reticulum-localized human papillomavirus type 16 E5 protein alters endosomal pH but not trans-Golgi pH. J Virol [Internet]. 2005;79. Available from: https://doi.org/10.1128/JVI.79.9.5839-5846.2005
14.Duensing S, Münger K. Mechanisms of genomic instability in human cancer: insights from studies with human papillomavirus oncoproteins. Int J Cancer [Internet]. 2004;109. Available from: https://doi.org/10.1002/ijc.11691
15.Kasymova S, Harrison SE, Pascal C. Knowledge and Awareness of Human Papillomavirus Among College Students in South Carolina. Infectious Diseases: Research and Treatment. 2019 Jan;12:117863371882507.
16.O’Brien MR, Rosenthal MS, Dharmarajan K, Krumholz HM. Balloon animals, guitars, and fewer blood draws: Applying strategies from pediatrics to the treatment of hospitalized adults. Vol. 162, Annals of Internal Medicine. American College of Physicians; 2015. p. 726–7.
17.Graham JE, Mishra A. Global challenges of implementing human papillomavirus vaccines. Vol. 10, International Journal for Equity in Health. 2011.
18.Branković I, Verdonk P, Klinge I. Applying a gender lens on human papillomavirus infection: Cervical cancer screening, HPV DNA testing, and HPV vaccination. Int J Equity Health. 2013;12(1).
19.Charde SH, Warbhe RA. Human Papillomavirus Prevention by Vaccination: A Review Article. Cureus. 2022 Oct 7;
20.Devaraja K, Aggarwal S, Verma SS, Gupta SC. Clinico-pathological peculiarities of human papilloma virus driven head and neck squamous cell carcinoma: A comprehensive update. Vol. 245, Life Sciences. Elsevier Inc.; 2020.
21.Dönmez S, Öztürk R, Kısa S, Karaoz Weller B, Zeyneloğlu S. Knowledge and perception of female nursing students about human papillomavirus (HPV), cervical cancer, and attitudes toward HPV vaccination. Journal of American College Health. 2019 Jul 4;67(5):410–7.
22.Kolar SK, Wheldon C, Hernandez ND, Young L, Romero-Daza N, Daley EM. Human Papillomavirus Vaccine Knowledge and Attitudes, Preventative Health Behaviors, and Medical Mistrust Among a Racially and Ethnically Diverse Sample of College Women. J Racial Ethn Health Disparities. 2015 Mar 1;2(1):77–85.
23.Leung SOA, Akinwunmi B, Elias KM, Feldman S. Educating healthcare providers to increase Human Papillomavirus (HPV) vaccination rates: A Qualitative Systematic Review. Vol. 3, Vaccine: X. Elsevier Ltd; 2019.
24.Lieber M, Reynolds CW, Lieb W, McGill S, Beddoe AM. Human papillomavirus knowledge, attitudes, practices, and prevalence among men who have sex with men in Monrovia, Liberia. J Low Genit Tract Dis. 2018 Oct 1;22(4):326–32.
25.Lott BE, Okusanya BO, Anderson EJ, Kram NA, Rodriguez M, Thomson CA, et al. Interventions to increase uptake of Human Papillomavirus (HPV) vaccination in minority populations: A systematic review. Vol. 19, Preventive Medicine Reports. Elsevier Inc.; 2020.
26.Nazer Ali A, Ping NY, Prajapati SK, Pheng LC, Iqbal MZ, Ahmed NZ. Effect of intervention in increasing knowledge and awareness of Human Papilloma Virus (HPV) infection and HPV vaccination among graduate students in a private university, Kedah state, Malaysia. MOJ Bioequivalence & Bioavailability. 2018 Jul 30;5(4).
27.Allen JD, Coronado GD, Williams RS, Glenn B, Escoffery C, Fernandez M, et al. A systematic review of measures used in studies of human papillomavirus (HPV) vaccine acceptability. Vol. 28, Vaccine. 2010. p. 4027–37.
28.Agénor M, McCauley HL, Peitzmeier SM, Haneuse S, Gordon AR, Potter J, et al. Sex of Sexual Partners and Human Papillomavirus Vaccination among U.S. Girls and Women. Am J Prev Med. 2016 Mar 1;50(3):318–27.
29.Gerend MA, Madkins K, Phillips G, Mustanski B. Predictors of human papillomavirus vaccination among young men who have sex with men. Sex Transm Dis. 2016;43(3):185–91.
30.Meites E, Krishna NK, Markowitz LE, Oster AM. Health care use and opportunities for human papillomavirus vaccination among young men who have sex with men. Sex Transm Dis. 2013 Feb;40(2):154–7.
31.Pask EB, Rawlins ST. Men’s Intentions to Engage in Behaviors to Protect Against Human Papillomavirus (HPV): Testing the Risk Perception Attitude Framework. Health Commun. 2016 Feb 1;31(2):139–49.
32.Porsch LM, Zhang H, Dayananda I, Dean G. Comparing Receipt of Cervical Cancer Screening and Completion of Human Papillomavirus Vaccination Using a New Construct of Sexual Orientation: A Serial Cross-Sectional Study. LGBT Health. 2019 May 1;6(4):184–91.